MADISON AUSTIN: Open Payments
NPI 1962097675 · DEL CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 97 payments from 26 companies in 2025. Trend: 2023 $1,765 · 2024 $1,647 · 2025 $1,891
Food & beverage: $1,891
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 9 | $180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $163 |
| Sequel Med Tech, LLC | 8 | $161 |
| Xeris Pharmaceuticals, Inc. | 8 | $144 |
| Lilly USA, LLC | 9 | $134 |
| Insulet Corporation | 5 | $124 |
| Novo Nordisk Inc | 7 | $116 |
| BETA BIONICS, INC. | 5 | $107 |
| Mannkind Corporation | 4 | $106 |
| Corcept Therapeutics | 5 | $101 |
Products named: Dexcom G6 Transmitter, JARDIANCE, TWIIST, MOUNJARO, Omnipod, iLet Bionic Pancreas, AFREZZA, Korlym.
Industry payments across OK — which companies pay providers there.
